Joachim Havla

6.4k total citations
66 papers, 1.3k citations indexed

About

Joachim Havla is a scholar working on Pathology and Forensic Medicine, Neurology and Rheumatology. According to data from OpenAlex, Joachim Havla has authored 66 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Pathology and Forensic Medicine, 22 papers in Neurology and 16 papers in Rheumatology. Recurrent topics in Joachim Havla's work include Multiple Sclerosis Research Studies (43 papers), Peripheral Neuropathies and Disorders (16 papers) and Systemic Lupus Erythematosus Research (11 papers). Joachim Havla is often cited by papers focused on Multiple Sclerosis Research Studies (43 papers), Peripheral Neuropathies and Disorders (16 papers) and Systemic Lupus Erythematosus Research (11 papers). Joachim Havla collaborates with scholars based in Germany, United States and Slovakia. Joachim Havla's co-authors include Reinhard Hohlfeld, Tania Kümpfel, Tania Kuempfel, Markus Krumbholz, Edgar Meinl, Hannah Pellkofer, Lisa Ann Gerdes, Ingrid Meinl, Bernhard Hemmer and Achim Berthele and has published in prestigious journals such as PLoS ONE, Neurology and Cochrane Database of Systematic Reviews.

In The Last Decade

Joachim Havla

62 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joachim Havla Germany 20 936 559 270 265 240 66 1.3k
K. Beckmann Germany 24 1.4k 1.5× 552 1.0× 335 1.2× 655 2.5× 197 0.8× 38 2.1k
M. Rodegher Italy 14 907 1.0× 478 0.9× 165 0.6× 279 1.1× 80 0.3× 18 1.0k
In Hye Jeong South Korea 18 693 0.7× 525 0.9× 126 0.5× 222 0.8× 128 0.5× 32 1.0k
Robert Glanzman United States 9 529 0.6× 354 0.6× 156 0.6× 128 0.5× 101 0.4× 14 1.1k
Xiaonan Zhong China 20 602 0.6× 451 0.8× 88 0.3× 207 0.8× 221 0.9× 46 1.0k
Shuhei Nishiyama Japan 21 1.3k 1.4× 1.1k 2.0× 137 0.5× 434 1.6× 333 1.4× 65 1.8k
Francisco Coret Spain 18 611 0.7× 332 0.6× 175 0.6× 156 0.6× 98 0.4× 36 762
Marc Coustans France 10 689 0.7× 338 0.6× 249 0.9× 197 0.7× 78 0.3× 10 878
Takaaki Ishizu Japan 15 733 0.8× 556 1.0× 146 0.5× 250 0.9× 277 1.2× 22 1.2k
L. P. Weiner United States 9 1.7k 1.8× 834 1.5× 427 1.6× 562 2.1× 177 0.7× 11 2.1k

Countries citing papers authored by Joachim Havla

Since Specialization
Citations

This map shows the geographic impact of Joachim Havla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joachim Havla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joachim Havla more than expected).

Fields of papers citing papers by Joachim Havla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joachim Havla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joachim Havla. The network helps show where Joachim Havla may publish in the future.

Co-authorship network of co-authors of Joachim Havla

This figure shows the co-authorship network connecting the top 25 collaborators of Joachim Havla. A scholar is included among the top collaborators of Joachim Havla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joachim Havla. Joachim Havla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaufmann, Elisabeth, Johannes Levin, Sonja Schönecker, et al.. (2024). Characterization of Peripapillary Hyperreflective Ovoid Mass-like Structures in a Broad Spectrum of Neurologic Disorders. Ophthalmology. 132(5). 590–597. 2 indexed citations
2.
Havla, Joachim, et al.. (2024). Multivariable prognostic prediction of efficacy and safety outcomes and response to fingolimod in people with relapsing-remitting multiple sclerosis. Multiple Sclerosis and Related Disorders. 93. 106247–106247. 1 indexed citations
3.
Samadzadeh, Sara, Joachim Havla, Klaudia Lepka, et al.. (2024). High socioeconomic impact on prescription behavior despite unrestricted access to disease-modifying therapies in people with multiple sclerosis. Frontiers in Immunology. 15. 1458458–1458458.
4.
Pfeuffer, Steffen, S. Wolff, Leoni Rolfes, et al.. (2024). Association of Clinical Relapses With Disease Outcomes in Multiple Sclerosis Patients Older Than 50 Years. Neurology. 103(2). e209574–e209574. 3 indexed citations
5.
Kuempfel, Tania, et al.. (2023). NMOSD IgG Impact Retinal Cells in Murine Retinal Explants. Current Issues in Molecular Biology. 45(9). 7319–7335. 1 indexed citations
6.
Reeve, Kelly, Joachim Havla, Jacob Burns, et al.. (2023). Prognostic models for predicting clinical disease progression, worsening and activity in people with multiple sclerosis. Cochrane Database of Systematic Reviews. 2023(9). CD013606–CD013606. 15 indexed citations
8.
Graf, Jonas, Verena I. Leussink, Klaudia Lepka, et al.. (2021). Relapse-independent multiple sclerosis progression under natalizumab. Brain Communications. 3(4). fcab229–fcab229. 26 indexed citations
9.
Motamedi, Seyedamirhosein, Frederike Cosima Oertel, Sunil Kumar Yadav, et al.. (2020). Altered fovea in AQP4-IgG–seropositive neuromyelitis optica spectrum disorders. Neurology Neuroimmunology & Neuroinflammation. 7(5). 35 indexed citations
10.
Abdelhak, Ahmed, André Huss, Alexander Stahmann, et al.. (2020). Explorative study of emerging blood biomarkers in progressive multiple sclerosis (EmBioProMS): Design of a prospective observational multicentre pilot study. Contemporary Clinical Trials Communications. 18. 100574–100574. 5 indexed citations
11.
Aly, Lilian, Joachim Havla, Gildas Lepennetier, et al.. (2020). Inner retinal layer thinning in radiologically isolated syndrome predicts conversion to multiple sclerosis. European Journal of Neurology. 27(11). 2217–2224. 22 indexed citations
12.
Reeve, Kelly, Joachim Havla, Jacob Burns, et al.. (2020). Prognostic models for predicting clinical disease progression, worsening and activity in people with multiple sclerosis. Cochrane Database of Systematic Reviews. 4 indexed citations
13.
Thaler, Franziska, et al.. (2020). Possible link of genetic variants to autoimmunity in GAD-antibody-associated neurological disorders. Journal of the Neurological Sciences. 413. 116860–116860. 11 indexed citations
14.
Oertel, Frederike Cosima, Olivier Outteryck, Benjamin Knier, et al.. (2019). Optical coherence tomography in myelin-oligodendrocyte-glycoprotein antibody-seropositive patients: a longitudinal study. Journal of Neuroinflammation. 16(1). 154–154. 44 indexed citations
15.
Förster, Moritz, Patrick Küry, Orhan Aktaş, et al.. (2019). Managing Risks with Immune Therapies in Multiple Sclerosis. Drug Safety. 42(5). 633–647. 13 indexed citations
16.
Oertel, Frederike Cosima, Joachim Havla, Adriana Roca‐Fernández, et al.. (2018). Retinal ganglion cell loss in neuromyelitis optica: a longitudinal study. MDC Repository (Max-Delbrueck-Center for Molecular Medicine). 14 indexed citations
17.
Unterrainer, Marcus, Christoph Mahler, Lena Vomacka, et al.. (2018). TSPO PET with [18F]GE-180 sensitively detects focal neuroinflammation in patients with relapsing–remitting multiple sclerosis. European Journal of Nuclear Medicine and Molecular Imaging. 45(8). 1423–1431. 47 indexed citations
18.
Schönecker, Sonja, Matthias Brendel, Joachim Havla, et al.. (2016). Tau-PET imaging with THK-5351 in patients with clinically diagnosed progressive supranuclear palsy. Journal of Neurochemistry. 406–407. 1 indexed citations
19.
Havla, Joachim. (2012). Rebound of Disease Activity After Withdrawal of Fingolimod (FTY720) Treatment. Archives of Neurology. 69(2). 262–262. 89 indexed citations
20.
Havla, Joachim, et al.. (2009). Cytotoxic and genotoxic effects of matrices for cartilage tissue engineering. Toxicology Letters. 190(2). 128–133. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026